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Introduction
Bioaerosols exposure and potential impact on human
health is a growing concern. Bioaerosols are assemblies of
particles of variable biological origin (bacterial, viral, or
fungal) suspended in the air and capable of initiating an
infectious process in a susceptible host. They usually con-
sist of a mixture of mono-dispersed and aggregate cells,
spores, or viruses, carried by other materials, such as
respiratory secretions. With rapid desiccation, the resul-
tant smaller aerosols can remain airborne longer, while
larger aerosols may initially fall out and then become re-
suspended after desiccation.
Objectives
Tests show that filter materials are very efficient at
removing small particles (< 0.1 of um diameter) from air
streams because electrostatic charge and Brownian
motion trap these fine particles within the matrix of the
fabric. Larger particles (>1.0um in diameter) such as bac-
teria or fungi are also efficiently removed by mechanical
filtration. However, filtration media are generally poor at
removing particles in the range from 0.1um to 0.5um in
diameter, which are small enough to escape the forces of
mechanical filtration yet are large enough to avoid being
entrapped by electrostatic or Brownian motion. This
“weakness window” unfortunately corresponds to the
mean size of many viruses.
Methods
Viroblock’s proprietary antiviral technology uses a combi-
nation of aliphatic lipidic chains, able to form lamellar
structures, and specific cyclodextrins to inactivate envel-
oped viruses. The mode of action is based on cholesterol
depletion from the viral membranes and, because choles-
terol is present in most viral envelopes, the technology is
active on all enveloped viruses tested so far. Importantly,
when coated on non-woven fabrics, Viroblock’s technol-
ogy retains its whole antiviral property.
Results
Aerosol challenges were performed on a prototype anti-
viral facemask composed of a filtration layer associated to
a Viroblock-coated external layer. Results show an overall
reduction of more than five Log TCID50 (99.9997 %) of
human Influenza virus H1N1.
Conclusion
The broad spectrum activity coupled to the extreme rapid-
ity of cholesterol depletion is opening the way to making
antimicrobial fabrics that can inactivate air borne viruses
during the very short time it takes for them to pass
through a filter, hence providing an increased protection
against bioaerosols of viral origin.
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